Calithera Biosciences, Inc.
CALA
$0.0001
$0.000.00%
OTC PK
| 12/31/2022 | 09/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -26.14% | -16.90% | |||
| Gross Profit | 26.14% | 16.90% | |||
| SG&A Expenses | -16.08% | -14.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -22.88% | -16.26% | |||
| Operating Income | 22.88% | 16.26% | |||
| Income Before Tax | 29.24% | -7.99% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 29.24% | -7.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 29.24% | -7.99% | |||
| EBIT | 22.88% | 16.26% | |||
| EBITDA | 23.07% | 16.34% | |||
| EPS Basic | 29.31% | -223.70% | |||
| Normalized Basic EPS | 29.31% | -7.94% | |||
| EPS Diluted | 29.31% | -26.50% | |||
| Normalized Diluted EPS | 29.31% | -26.49% | |||
| Average Basic Shares Outstanding | 0.10% | 0.04% | |||
| Average Diluted Shares Outstanding | 0.10% | -14.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||